Invitae (NVTA) News Today → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free NVTA Stock Alerts $0.0090 +0.01 (+-1,000.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLabcorp to acquire Invitae assets for $239 millionuk.investing.com - April 26 at 8:57 AMLabcorp wins $239M bid for bankrupt Invitaebizjournals.com - April 26 at 8:57 AMLabcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Dealmsn.com - April 25 at 5:56 PMInvitae Corporation: Invitae Enters into Agreement with Labcorp for Sale of Businessfinanznachrichten.de - April 25 at 12:55 PMLabcorp to Buy Assets of Bankrupt Invitae for $239Mmarketwatch.com - April 25 at 7:55 AMClinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mlnreuters.com - April 24 at 10:25 PMInvitae Enters into Agreement with Labcorp for Sale of Businessfinance.yahoo.com - April 24 at 9:54 PMLabcorp Announces Winning Bid for Select Assets of Invitaeprnewswire.com - April 24 at 9:27 PMInvitae (NYSE:NVTA) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 23 at 2:14 AMInvitae Publishes its Environmental, Social and Governance (ESG) Reporttmcnet.com - April 22 at 6:26 PMInvitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significancefinance.yahoo.com - April 11 at 1:32 PMInvitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significanceprnewswire.com - April 11 at 11:30 AMPioneering cancer test company wants court to slow potential sale of Invitae's cancer-monitoring productsbizjournals.com - April 2 at 8:52 PMInvitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classificationfinance.yahoo.com - March 12 at 9:55 AMNVTA.PKreuters.com - March 11 at 7:21 PMNVTA.Nreuters.com - March 9 at 7:13 PMInvitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 6 at 5:56 PMInvitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Resultsprnewswire.com - March 6 at 7:15 AMInvitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meetingprnewswire.com - March 5 at 7:30 AMNVTA Jun 2024 0.500 putfinance.yahoo.com - March 3 at 11:03 PMNVTA Jan 2026 1.500 callfinance.yahoo.com - February 26 at 12:20 AMNVTA Mar 2024 0.500 putfinance.yahoo.com - February 17 at 12:16 AMInvitae gets court approval for five-month bankruptcy salemsn.com - February 15 at 5:26 PMGenetic testing pioneer Invitae files for bankruptcy protectionbizjournals.com - February 15 at 7:25 AMGenetic Test Provider Invitae (OTC:NVTA) Files for Bankruptcymsn.com - February 14 at 3:37 PMGenetic test maker Invitae files for bankruptcy protection in USmsn.com - February 14 at 12:05 AMInvitae Files for Voluntary Chapter 11 Protection; Pursues Sale Processfinance.yahoo.com - February 14 at 12:05 AMGenetic test maker Invitae files for bankruptcy protection in USreuters.com - February 13 at 11:07 PMInvitae Files for Voluntary Chapter 11 Protection; Pursues Sale Processprnewswire.com - February 13 at 10:07 PMInvitae Corp.edition.cnn.com - February 9 at 10:22 AMNVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcyinvestorplace.com - February 6 at 11:00 AMNYSE to Commence Delisting Proceedings Against Invitae Corporation (NVTA)finance.yahoo.com - February 6 at 9:43 AMmarketbeat.com - February 6 at 9:06 AMInvitae Corporation: Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeuticsfinanznachrichten.de - February 6 at 4:42 AMWhy Is Invitae (NVTA) Stock Down 75% Today?investorplace.com - February 5 at 3:05 PMmarketbeat.com - February 5 at 2:45 PMMedical test maker Invitae prepares for bankruptcy - WSJreuters.com - February 5 at 12:29 PMInvitae plunges amid report it may file for bankruptcy within weeksmsn.com - February 5 at 12:29 PMInvitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeuticsfinance.yahoo.com - January 30 at 7:33 AMInvitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeuticsfinance.yahoo.com - January 30 at 7:33 AMInvitae cuts loose another business unit, more jobs to continue to reduce cash burnbizjournals.com - January 24 at 3:41 PMNatera Acquires Reproductive Health Assets from Invitaefinance.yahoo.com - January 22 at 9:55 AMNatera Acquires Assets From Invitaemarkets.businessinsider.com - January 22 at 9:55 AMInvitae offloads reproductive health assets to Nateramsn.com - January 22 at 9:55 AMInvitae Completes Sale of Reproductive Health Assets to Naterafinance.yahoo.com - January 22 at 9:55 AMInvitae (NYSE:NVTA) Lifted to "Hold" at StockNews.commarketbeat.com - December 29 at 1:07 AMDespite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stockfinance.yahoo.com - December 22 at 1:07 PMInvitae (NYSE:NVTA) Lowered to "Sell" at StockNews.commarketbeat.com - December 21 at 1:10 AMDeeply unprofitable biotech company Invitae lays off 238 San Francisco workersmsn.com - December 20 at 9:16 AMNVTA Jan 2024 1.500 putca.finance.yahoo.com - December 17 at 12:20 AM Get Invitae News Delivered to You Automatically Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. NVTA Media Mentions By Week NVTA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVTA News Sentiment▼0.160.33▲Average Medical News Sentiment NVTA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVTA Articles This Week▼102▲NVTA Articles Average Week Get Invitae News Delivered to You Automatically Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACON News ALLR News SINT News ADTX News BTTX News MOTS News BLPH News AMPE News APVO News SXTC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVTA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invitae Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
